BioCorRx (BICX) Net Cash Flow Growth (1y) (2011 - 2026)
BioCorRx (BICX) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | 88.81% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 520.00% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 91.33% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 20,266.67% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 119.58% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | -568.10% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 262.02% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | -1,190.49% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | -67.90% |
| 10 | BioCorRx | - | - | 189,355.00 | 213.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 213.55% |
| Dec 31, 2025 | -268.66% |
| Sep 30, 2025 | 2,224.66% |
| Jun 30, 2025 | 194.62% |
| Mar 31, 2025 | -278.18% |
| Dec 31, 2024 | 196.44% |
| Sep 30, 2024 | 79.77% |
| Jun 30, 2024 | -1,352.53% |
| Mar 31, 2024 | -73.45% |
| Dec 31, 2023 | -1,892.90% |
| Sep 30, 2023 | 14.68% |
| Jun 30, 2023 | 93.72% |
| Mar 31, 2023 | 6.08% |
| Dec 31, 2022 | 100.77% |
| Sep 30, 2022 | -213.32% |
| Jun 30, 2022 | 91.57% |
| Mar 31, 2022 | -90.34% |
| Dec 31, 2021 | -91.66% |
| Sep 30, 2021 | 108.01% |
| Jun 30, 2021 | -138.14% |